It is an extract of natural porcine lung surfactant consisting of 99% polar lipids mainly phospholipids and 1 % hydrophobic low molecular. There are no data on the use of poractant alfa curosurf during lactation. First generation protein free synthetic surfactants are not used nowadays. Pdf a randomized, multicenter masked comparison trial of. Beractant and poractant alfa in premature neonates with. Likewise, another study comparing lucinactant with poractant alfa was considered underpowered to draw conclusions about equivalence, and the product has not been licensed for use in newborns. Mary ellen avery soon after showed that the lungs of premature infants couldnt produce surfactants.
Curosurf poractant alfa dosing, indications, interactions. Sales of curosurfr poractant alfa, a pulmonary surfactant, exceeded euro200m, growing by 14. Bovine surfactants are known to be clinically equivalent but it is unclear if porcine or bovine surfactants at their licensed dose should be preferred to treat respiratory distress syndrome in preterm neonates. Porcine vs bovine surfactant therapy for preterm neonates. Pulmonary distribution of lucinactant and poractant alfa. It is a natural porcine lung extract consisting of 99% polar lipids mainly phospholipids and approximately 1% hydrophobic low molecular weight proteins surfactant associated proteins spb and spc. Despite the theoretical advantages of proteinfree synthetic surfactants and their. This web page contains comprehensive information about ndc code 1012251003. Poractant alfa is a pulmonary surfactant sold under the brand name curosurf by chiesi. Respiratory distress syndrome rds, also known as hyaline membrane disease, is one of the leading causes of infant mortality in the united states.
Compared with nrds group, when treated with budesonide and poractant alfa, ros levels decreased, senp1 decreased, nuclear sirt1 increased p poractant alfa can prevent bpd in preterm infants by activating the sirt1 signaling pathway. Further randomized prospective studies on these surfactants are needed. The administration of poractant curosurf through a duallumen endotracheal. A study on the safety and efficacy of reveglucosidase alfa. Pulmonary distribution of lucinactant and poractant alfa and their peridosing hemodynamic effects in a preterm lamb model of respiratory distress syndrome. Stopping the trial early may have widened the difference between the treatment groups.
Exogenous surfactant therapy increases the pool size rapidly and improves. They lower surface tension at the interface between the air in the lungs, specifically at the alveoli, and the blood in the capillaries. Objectives to compare the efficacy and safety of poractant alfa and bovine lipid extract surfactant in preterm infants. To address this limitation, reveglucosidase alfa, a novel insulinlike growth factor 2 igf2tagged gaa analogue with improved lysosomal uptake, was developed.
Your doctor will tell you when your child should not receive this medicine. Prevention is generally done in babies born less than 32 weeks gestational age. Pulmonary surfactants, beractant, poractant alfa, calfactant, respiratory distress syndrome. Therefore, infants receiving curosurf should receive frequent clinical and laboratory assessments so that oxygen and ventilatory support can be modified to respond to respiratory changes. Pdf beractant and poractant alfa in premature neonates. As with other surfactants, marked improvement on oxygenation may occur within minutes of the administration of poractant alfa. Twelve infants died before discharge, 9 in the poractant alfa group and 3 in the bovine lung extract group. Curosurf poractant alfa intratracheal suspension is a sterile, nonpyrogenic pulmonary surfactant intended for intratracheal use only. Yes, because it is an exogenous surfactant agent used for newborns experiencing signs of rds. Highlights of prescribing information these highlights do. Efficacy of surfactantta, calfactant and poractant alfa. Poractant alfa should only be administered to pregnant women where the potential benefit of the medication would outweigh the unknown risks to the fetus. Each ml of suspension contains 80 mg poractant alfa surfactant extract that includes 76 mg of phospholipids and 1 mg of protein of which 0. Poractant alfa drug bnfc content published by nice.
An open label comparison of calfactant and poractant alfa administration traits and impact on neonatal intensive care unit resources. Would recommending poractant alfa to a 28week gestational aged newborn weighing grams that exhibits symptoms of rds be a good move. Each ml of suspension contains 80 mg poractant alfa surfactant extract. Term neonates usually have a surfactant storage pool of approximately 100 mgkg, whereas preterm neonates have an estimated pool only 45 mgkg at birth. These highlights do not include all the information needed to use.
A pharmacoeconomic analysis of inhospital costs resulting. Pulmonary surfactant is used as a medication to treat and prevent respiratory distress syndrome in newborn babies. Efficacy of surfactantta, calfactant and poractant alfa for. The administration of exogenous surfactants, including curosurf, can rapidly affect oxygenation and lung compliance.
Springer nature is making sarscov2 and covid19 research free. Pulmonary surfactants, beractant, poractant alfa, calfactant, respira. Efficacy of porcine versus bovine surfactants for preterm. Nebulization of poractant alfa via a vibrating membrane. Find information about common, infrequent and rare side effects of poractant alfa intratracheal.
Poractant alfa versus bovine lipid extract surfactant for. A search of major electronic databases, including medline 19802010 and the cochrane central register of controlled trials, for randomized controlled trials that. The primary outcome was being alive and extubated at 48 hours post. Poractant alfa is an extract of natural porcine lung surfactant consisting of 99% polar lipids mainly phospholipids and 1% hydrophobic low molecular weight proteins surfactant associated proteins spb and spc. Pdf we compared the onset of clinical response and safety of two surfactants, poractant alfa curosurf. Curosurf poractant alfa is a sterile, nonpyrogenic pulmonary surfactant intended for intratracheal use only. Capitals indicate lifethreatening, underlines indicate most frequent. Follow instructions carefully regarding installation of drug and ventilation of infant. Pdf comparison of the pharmacoeconomics of calfactant. Curosurf definition of curosurf by medical dictionary. Group 1 n146, surfactantta, group 2 n96, calfactant, and group 3 n90, poractant alfa. There were no differences between studies or treatment groups in the overall extubation rate.
Fill the catheter with poractant alfa and discard excess through the catheter so that only the total dose to be given remains in the syringe. Poractant alpha 2015 neomed consensus group poractant alpha page 1 of 4 this is a printed copy. Uses for poractant alfa respiratory distress syndrome rds treatment rescue of rds hyaline membrane disease in premature neonates designated an orphan drug by fda for this use. A total of 332 preterm infants at 2431 weeks gestation with respiratory distress syndrome rds were enrolled and allocated to three groups according to the surfactant instilled. Poractant alfa is a pulmonary surfactant sold under the brand name curosurf by chiesi farmaceutici. Bovine lung phospholipid injection, poractant alfa injection, continuous positive airway pressure, hya. Curosurf poractant alfa dose, indications, adverse effects. This study evaluated the pharmacokinetics, safety, and exploratory efficacy of reveglucosidase alfa in 22 subjects with lateonset pompe disease who were previously untreated with rhgaa. Poractant alfa drug information indications, dosage, side.
Poractant alfa is a sterile, nonpyrogenic pulmonary surfactant intended for intratracheal use only. Curosurf poractant alfa is intended for intratracheal use only. Study design randomized, partiallyblinded, multicenter trial. Since data are not available, poractant alfa should be administered with caution during breastfeeding. Refer to electronic neomed system for the most up to date version. Curosurf there may be other brand names for this medicine.
Overall mortality and morbidities were similar between groups. This was the first study comparing the efficacy of surfactantta, calfactant, and poractant alfa in a large number of preterm infants in korea. Aug 31, 2015 in our study, we used poractant alfa, an animalderived surfactant which proved to be advantageous compared to different surfactant preparations regarding rapid onset of action, less need for. Jun 28, 2018 curosurf is administered via the endotracheopulmonary route in infants whose heart rate and arterial oxygen concentration or oxygen saturation are being continuously monitored as it is usually feasible in neonatal units. Poractant alfa is an extract of natural porcine lung surfactant consisting of 99% polar lipids mainly phospholipids and 1% hydrophobic low molecular weight proteins surfactant associated proteins spb. Pdf comparison of the pharmacoeconomics of calfactant and.
Drug information curosurf poractant alfa install pdr s official, free drug information and comparison app today. Curosurf is a white to creamy white suspension of poractant alfa. Poractant alfa is an extract of natural porcine lung surfactant. Treatment with poractant alfa 200 mgkg initial dose resulted in rapid reduction in supplemental. Pumactant and poractant alfa for treatment of respiratory. Curosurf 120mg vial endotracheopulmonary instillation. Curosurf poractant alfa dosing, indications, interactions, adverse. Survival free of bronchopulmonary dysplasia bpd at the end of study period was 78. Prophylactic protein free synthetic surfactant for. Beractant and poractant alfa in premature neonates with respiratory distress syndrome. Mortality was unexpectedly lower among neonates who received poractant alfa than among those who received pumactant, and was independent of all the variables we investigated.
To compare the efficacy of a porcine surfactant poractant alfa versus bovine surfactants beractant and calfactant with respect to clinical outcomes among preterm infants with respiratory distress syndrome. Researcher john clements identified surfactants and their role in the 1950s. Compared with nrds group, when treated with budesonide and poractant alfa, ros levels decreased, senp1 decreased, nuclear sirt1 increased p free pdf download. Curosurf poractant alfa dose, indications, adverse. If you need an aap account free for anyone to register an account, please click on create account below and complete the onetime registration form.
Curosurf is a natural surfactant, prepared from porcine lungs, containing almost exclusively polar lipids, in particular phosphatidylcholine about 70% of the total phospholipid content, and about 1% of specific low molecular weight hydrophobic. Poractant alfa curosurf extracted from material derived from minced pig lung. Curosurf poractant alfa for the treatment of infants at risk for or. Curosurf aka poractant alfa is a human prescription drug product labeled by chiesi usa, inc. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. It is an extract of natural porcine lung surfactant consisting of 99% polar lipids mainly phospholipids and 1% hydrophobic low molecular weight proteins surfactant associated proteins spb and spc. The related drug information index provides comprehensive access to all drug information related to a specific drug types of content include full prescribing information, drug summaries, full prescribing information.
The nlm drug information portal gives users a gateway to selected drug information from the national library of medicine and other key government agencies. In vitro and in vivo characterization of poractant alfa. Medscape rescue treatment for respiratory distress syndrome dosing for curosurf poractant alfa, frequencybased adverse effects, comprehensive. Poractant alfa poraktant alfa prevents and treats certain lung problems in premature infants. Pdf an open label comparison of calfactant and poractant. Poractant alfa drug monograph pediatric care online. Infants poractant alfa or bovine lipid extract surfactant. Efficacy of surfactantta, calfactant and poractant alfa for preterm. Aug 22, 2019 uses for poractant alfa respiratory distress syndrome rds treatment rescue of rds hyaline membrane disease in premature neonates designated an orphan drug by fda for this use. Curosurf reduces mortality and pneumothoraces associated with rds. Budesonide and poractant alfa prevent bronchopulmonary. The cost of comparable doses of poractant alfa and calfactant show that calfactant is less expensive than poractant alfa for most situations. Poractant alfa definition of poractant alfa by medical.
Common and rare side effects for poractant alfa intratracheal. Curosurf poractant alfa intratracheal suspension is indicated for the rescue treatment of respiratory distress syndrome rds in premature infants. Poractant alfa versus beractant in the treatment of preterm. Poractant alfa drug monograph pediatric care online aap. Important safety information curosurf is intended for intratracheal use only. For neonate 24 weeks to 31 weeks corrected gestational age. Comparison of approved natural surfactants youtube. Learn how to pronounce the drugs name, its indications, dosage, how to.
Curosurf is an extract of natural porcine lung surfactant consisting of 99% polar lipids mainly phospholipids and 1% hydrophobic low molecular weight proteins. Pdf beractant and poractant alfa in premature neonates with. Refer to specific instruction provided by manufacturer for proper dosing technique. Comparison of the efficacy and safety of bovine lung phospholipid. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Average mv duration following reintubation was similar between groups in both trials.
1007 246 998 1602 600 429 50 1216 458 293 576 366 663 1323 551 94 1206 1215 644 1054 400 924 850 544 963 930 261 814 245